There were 1,435 press releases posted in the last 24 hours and 405,789 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
RECOVER Clinical Study Shows Meaningful Benefits of LivaNova’s VNS Therapy System in Select Secondary Endpoints for Unipolar Patients with Treatment-Resistant Depression

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.